1. Home
  2. THRD vs BMNR Comparison

THRD vs BMNR Comparison

Compare THRD & BMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • BMNR
  • Stock Information
  • Founded
  • THRD 2019
  • BMNR 2019
  • Country
  • THRD United States
  • BMNR United States
  • Employees
  • THRD N/A
  • BMNR N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • BMNR
  • Sector
  • THRD Health Care
  • BMNR
  • Exchange
  • THRD Nasdaq
  • BMNR NYSE
  • Market Cap
  • THRD 238.7M
  • BMNR 205.5M
  • IPO Year
  • THRD 2022
  • BMNR N/A
  • Fundamental
  • Price
  • THRD $5.46
  • BMNR $40.73
  • Analyst Decision
  • THRD Hold
  • BMNR
  • Analyst Count
  • THRD 3
  • BMNR 0
  • Target Price
  • THRD $5.00
  • BMNR N/A
  • AVG Volume (30 Days)
  • THRD 220.4K
  • BMNR 14.8M
  • Earning Date
  • THRD 08-07-2025
  • BMNR 07-11-2025
  • Dividend Yield
  • THRD N/A
  • BMNR N/A
  • EPS Growth
  • THRD N/A
  • BMNR N/A
  • EPS
  • THRD N/A
  • BMNR N/A
  • Revenue
  • THRD N/A
  • BMNR $5,452,545.00
  • Revenue This Year
  • THRD N/A
  • BMNR N/A
  • Revenue Next Year
  • THRD N/A
  • BMNR N/A
  • P/E Ratio
  • THRD N/A
  • BMNR N/A
  • Revenue Growth
  • THRD N/A
  • BMNR 89.77
  • 52 Week Low
  • THRD $3.18
  • BMNR $3.92
  • 52 Week High
  • THRD $16.02
  • BMNR $161.00
  • Technical
  • Relative Strength Index (RSI)
  • THRD 66.73
  • BMNR N/A
  • Support Level
  • THRD $5.42
  • BMNR N/A
  • Resistance Level
  • THRD $5.45
  • BMNR N/A
  • Average True Range (ATR)
  • THRD 0.04
  • BMNR 0.00
  • MACD
  • THRD -0.01
  • BMNR 0.00
  • Stochastic Oscillator
  • THRD 50.00
  • BMNR 0.00

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About BMNR BITMINE IMMERSION TECNOLOGIES INC

BitMine Immersion Technologies Inc is a blockchain technology company that is building out industrial-scale digital asset mining, equipment sales, and hosting operations. The company's primary business is data center focused, both mining Bitcoin for its account as well as hosting third-party Bitcoin mining servers. The Company's primary business is self-mining bitcoin for its own account, as well as hosting third-party equipment used in mining of digital asset coins and tokens, specifically bitcoin. Company's state of the art facilities will be specifically designed and constructed for housing mining equipment. The data centers will provide power, racks, proprietary thermodynamic management.

Share on Social Networks: